Emend Intravenous and Signifor (Pasireotide Extended-Release Injection)
Determining the interaction of Emend Intravenous and Signifor (Pasireotide Extended-Release Injection) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: fosaprepitant
Brand name: Emend for Injection
Synonyms: Fosaprepitant
Generic Name: pasireotide
Brand name: Signifor, Signifor LAR
Synonyms: Signifor, Signifor Injection
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emend Intravenous-Signifor (Pasireotide Injection)
- Emend Intravenous-Signifor Injection
- Emend Intravenous-Signifor LAR
- Emend Intravenous-Signifor LAR Injection
- Emend Intravenous-Siklos
- Emend Intravenous-Siladryl Allergy
- Signifor (Pasireotide Extended-Release Injection)-Emflaza
- Signifor (Pasireotide Extended-Release Injection)-Emflaza (Deflazacort Oral Suspension)
- Signifor (Pasireotide Extended-Release Injection)-Emflaza (Deflazacort Tablets)
- Signifor (Pasireotide Extended-Release Injection)-Emicizumab
- Signifor (Pasireotide Extended-Release Injection)-Emicizumab-kxwh
- Signifor (Pasireotide Extended-Release Injection)-Emicizumab-kxwh Subcutaneous